Neuroendocrine tumors (NETs) are uncommon tumors with increasing incidence and
prevalence. Current reports suggest that 68Ga-DOTATATE PET/CT imaging improves …

68Ga-DOTATOC, a somatostatin receptor–targeted ligand, has been used clinically in
Europe over the past decade for imaging neuroendocrine tumors (NETs). It appears to be …

OBJECTIVE. The purpose of this article is to provide a review of the use of 68Ga
tetraazacyclododecanetetraacetic acid–DPhe1-Tyr3-octreotate (DOTATATE) PET/CT, a …

Background Gallium-68 somatostatin receptor positron emission tomography (PET) has
been used in the diagnosis of neuroendocrine tumors (NETs). The compounds often used in …

Our purpose was to evaluate the safety and efficacy of 68Ga-DOTATATE PET/CT compared
with 111In-pentetreotide imaging for diagnosis, staging, and restaging of pulmonary and …

Neuroendocrine tumors (NETs) are rare neoplasms that emerge mainly from the GI tract,
pancreas and respiratory tract. The incidence of NETs has increased more than sixfold in the …

Somatostatin receptor PET tracers such as [68Ga-DOTA, 1-Nal3]-octreotide (68Ga-
DOTANOC) and [68Ga-DOTA, Tyr3]-octreotate (68Ga-DOTATATE) have shown promising …

68Ga-DOTATATE PET/CT scanning is a widely accepted method for imaging of
neuroendocrine tumors. This cross-sectional study was performed to review the first 8 y of …

Several authors reported the superiority of 68Ga-DOTANOC PET/CT to conventional
imaging (CI) for the assessment of neuroendocrine tumors (NET). However, the detection of …

Objectives The aim of the present review was to assess the role of combined 18 F-
Fluorodeoxyglucose (F-18 FDG) and Ga-68 DOTA-peptides positron emission tomography …